BCL2 and hepatocellular carcinoma: Using the BH3-mimetic ABT-737, which inhibits Bcl-2, Bcl-XL and Bcl-W, induced apoptosis in HCC when Mcl-1 expression was simultaneously inhibited, e.g., by sorafenib [35].